✦ LIBER ✦

Acquired hemophilia A with sigmoid colon cancer: successful treatment with rituximab followed by sigmoidectomy

✍ Scribed by Satoshi Ichikawa; Katsura Kohata; Yoko Okitsu; Makiko Suzuki; Shinji Nakajima; Minami F. Yamada; Yasushi Onishi; Joji Yamamoto; Sozo Suzuki; Kenichi Ishizawa; Junichi Kameoka; Hideo Harigae

Book ID: 107618798
Publisher: Carden Jennings Publishing
Year: 2009
Tongue: English
Weight: 211 KB
Volume: 90
Category: Article
ISSN: 0925-5710
DOI: 10.1007/s12185-009-0347-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful treatment of acquired hemophi

Successful treatment of acquired hemophilia A, complicated by chronic GVHD, with tocilizumab

✍ Sumiyuki Nishida; Tomio Kawasaki; Hirokazu Kashiwagi; Atsuyoshi Morishima; Yoshi 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 157 KB

Successful treatment of S-1 + CDDP follo

Successful treatment of S-1 + CDDP followed by salvage EMR for a case with metastatic Barrett's esophageal cancer

✍ K. Nakatani; S. Tanabe; W. Koizumi; K. Nishimura; T. Shimoda; M. Azuma; C. Katad 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

Primary Systemic Amyloidosis Presenting

Primary Systemic Amyloidosis Presenting as a Colonic Stricture: Successful Treatment with Left Hemicolectomy Followed by Autologous Hematopoietic Stem-Cell Transplantation

✍ S. Rives; M. Pera; L. Rosiñol; O. Vidal; R. Miquel; M. Solé; J. García-Valdecasa 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 392 KB

Combination therapy with fludarabine and

Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma : A phase 2 trial of the Minnie Pearl Cancer Research Network

✍ John D. Hainsworth; Elizabeth R. Vazquez; David R. Spigel; Eric Raefsky; James D 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Abstract ## BACKGROUND The purpose of the current study was to evaluate the efficacy and toxicity of the combination of fludarabine and rituximab, followed by alemtuzumab, as first‐line treatment for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). ## METHO